Investtech's Model Portfolios fell in the third quarter with, on average, 2.1 percentage points in relation to the reference index. In particular, the portfolios for Norway and Germany drew the average down by returns of 9.6 and 6.1 percentage points weaker than the index. The portfolio for Finland beat the index by 7.2 percentage points.
Market | Excess ret. Q1* | Excess ret. Q2* | Excess ret. Q3* | Excess ret. Q4* | Excess ret. 2004 |
Stockholm | +3.7% | -0.5% | -5.2% | -2.0% | |
Helsinki | +3.9% | +11.8% | +7.2% | +22.9% | |
Amsterdam | +13.0% | +7.3% | +5.7% | +26.0% | |
Copenhagen | +13.5% | +5.1% | -2.6% | +16.0% | |
Oslo | -6.1% | -4.7% | -9.6% | -20.4% | |
London | +3.8% | -3.4% | -3.6% | -3.2% | |
Frankfurt/CDAX | +15.6% | -0.5% | -6.1% | +9.0% | |
Nasdaq | -2.7% | +14.5% | -2.9% | +8.9% | |
Average | +5.59% | +3.70% | -2.1% | +7.2% |
We believe the weak result for the last quarter is first and foremost due to statistical coincidences. The results so far this year have been good, with returns averaging 7.2 percentage points better than the reference index.
The strategy use previously is still considered to be good.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.